Tudorza (aclidinium bromide) reduces flare-ups in patients with moderate to severe chronic obstructive pulmonary disease (COPD) without increasing…
Articles by Joana Carvalho, PhD
The use of electronic cigarettes, more commonly known as vaping, triggers cellular responses in the lungs similar to those elicited…
Patients with chronic obstructive pulmonary disease (COPD) who are experiencing severe exacerbations should receive noninvasive ventilation, regardless of factors…
Nuvaira, a medical device company, announced the upcoming publication of several scientific studies detailing the findings of clinical trials…
Olympus‘ Spiration Valve System (SVS), a device that can be inserted into a patient’s airways to redirect air…
Patients with chronic obstructive pulmonary disease (COPD) are more susceptible to bone fractures and osteoporosis than those of the…
CSA Medical‘s RejuvenAir System received the designation of Breakthrough Device by the U.S. Food and Drug Administration (FDA) for…
The U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application for the addition of new…
The U.S. Food and Drug Administration (FDA) approved a new label for Stiolto Respimat (a combination therapy of…
Hospitalized patients with chronic obstructive pulmonary disease (COPD) who also suffer from atrial fibrillation (AFib), a condition where…